ARTICLE SUMMARY:
In this week’s roundup: Updates on China’s device approval numbers; a look at leading candidates for top FDA and CMS jobs; Sen. Cassidy probes CDRH on artificial intelligence/machine learning plans; COVID-19 relief moves forward; and DME bidding program hits more barriers.
China released its 2020 approval stats and its plans to revise aging device guidance documents. In the US, chatter around FDA and CMS nominations builds, COVID-19 relief proceeds, and the DME Medicare competitive bidding program appears to be languishing. More in this edition of Pathways’ Picks.
